Related Experiment Video
Updated: Aug 18, 2025
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Disease patterns of coronary heart disease and type 2 diabetes harbored distinct and shared genetic architecture
Han Xiao1, Yujia Ma1, Zechen Zhou1
1Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.
Insights
This study introduces a novel SNP-set approach to understand the genetic basis of coronary heart disease (CHD) and type 2 diabetes (T2D). Findings reveal distinct genetic architectures for different CHD and T2D disease patterns, offering new biological insights.
Area of Science:
- Genetics
- Cardiovascular Disease
- Metabolic Disorders
Background:
- Coronary heart disease (CHD) and type 2 diabetes (T2D) are complex, interrelated diseases.
- Traditional genetic studies often analyze single-nucleotide polymorphisms (SNPs) independently.
- A comprehensive understanding of their shared and distinct genetic architectures is needed.
Purpose of the Study:
- To develop and apply a genotypic-phenotypic framework for deciphering the genetic architecture of CHD and T2D.
- To explore the complex interrelationships between genetic variations and disease patterns.
- To identify distinct genetic networks underlying different disease manifestations.
Main Methods:
- Utilized a genome-wide association study with a data-driven SNP-set approach.
- Applied nonsmooth nonnegative matrix factorization (nsNMF) for clustering SNPs and subjects.
- Assessed relationships between SNP sets and phenotype sets, and constructed a genetic network.
Main Results:
- Identified 23 significant SNP sets associated with CHD or T2D.
- Demonstrated distinct SNP sets for different disease patterns (comorbidity, isolated CHD, isolated T2D).
- Revealed disjoint genetic networks with common genes (pleiotropy) underlying disease patterns, implicating pathways like fatty acid metabolism.
Conclusions:
- The SNP-set approach effectively deciphers complex genotype-phenotype relationships in CHD and T2D.
- Distinct genetic architectures underlie different disease patterns, with potential implications for lipid metabolism and fibrosis.
- Findings provide novel insights into biological pathways relevant to these complex diseases.
Background:
Coronary heart disease (CHD) and type 2 diabetes (T2D) are two complex diseases with complex interrelationships. However, the genetic architecture of the two diseases is often studied independently by the individual single-nucleotide polymorphism (SNP) approach. Here, we presented a genotypic-phenotypic framework for deciphering the genetic architecture underlying the disease patterns of CHD and T2D.
Method:
A data-driven SNP-set approach was performed in a genome-wide association study consisting of subpopulations with different disease patterns of CHD and T2D (comorbidity, CHD without T2D, T2D without CHD and all none). We applied nonsmooth nonnegative matrix factorization (nsNMF) clustering to generate SNP sets interacting the information of SNP and subject. Relationships between SNP sets and phenotype sets harboring different disease patterns were then assessed, and we further co-clustered the SNP sets into a genetic network to topologically elucidate the genetic architecture composed of SNP sets.
Results:
We identified 23 non-identical SNP sets with significant association with CHD or T2D (SNP-set based association test, P < 3.70 × [Formula: see text]). Among them, disease patterns involving CHD and T2D were related to distinct SNP sets (Hypergeometric test, P < 2.17 × [Formula: see text]). Accordingly, numerous genes (e.g., KLKs, GRM8, SHANK2) and pathways (e.g., fatty acid metabolism) were diversely implicated in different subtypes and related pathophysiological processes. Finally, we showed that the genetic architecture for disease patterns of CHD and T2D was composed of disjoint genetic networks (heterogeneity), with common genes contributing to it (pleiotropy).
Conclusion:
The SNP-set approach deciphered the complexity of both genotype and phenotype as well as their complex relationships. Different disease patterns of CHD and T2D share distinct genetic architectures, for which lipid metabolism related to fibrosis may be an atherogenic pathway that is specifically activated by diabetes. Our findings provide new insights for exploring new biological pathways.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:22Diabetes Mellitus: Type 2 and Gestational
01:26Coronary Artery Disease II: Pathophysiology
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...